Skip to main content

Articles

Page 246 of 330

  1. The WW domain containing protein WWOX has been postulated to behave as a tumor suppressor in breast and other cancers. Expression of this protein is lost in over 70% of ER negative tumors. This prompted us to ...

    Authors: Brent W Ferguson, Xinsheng Gao, Maciej J Zelazowski, Jaeho Lee, Collene R Jeter, Martin C Abba and C Marcelo Aldaz
    Citation: BMC Cancer 2013 13:593
  2. Neoadjuvant chemoradiotherapy has been newly included in the NCCN guidelines as a treatment option for stage IIB/III soft tissue sarcomas. Whether radiographic response to neoadjuvant therapy correlates with i...

    Authors: Yong Chen, Yun Yang, ChunMeng Wang and YingQiang Shi
    Citation: BMC Cancer 2013 13:591
  3. To assess the trends of risk classification and primary therapy in Japanese patients who were diagnosed with prostate cancer between 2004-2006 and 2007-2009.

    Authors: Nobumichi Tanaka, Akihide Hirayama, Tatsuo Yoneda, Katsunori Yoshida, Keiji Shimada, Noboru Konishi and Kiyohide Fujimoto
    Citation: BMC Cancer 2013 13:588
  4. The genetic changes in gastric adenocarcinoma are extremely complex and reliable tumor markers have not yet been identified. There are also remarkable geographical differences in the distribution of this disea...

    Authors: Lars L Eftang, Ying Esbensen, Tone M Tannæs, Gustav P Blom, Ida RK Bukholm and Geir Bukholm
    Citation: BMC Cancer 2013 13:586
  5. Desmoplastic small round cell tumor (DSRCT) is characterized by the presence of a fusion protein EWS/WT1, arising from the t (11;22) (p13;q12) translocation. Here we examine the oncogenic properties of two spl...

    Authors: Pratiti Bandopadhayay, Anissa M Jabbour, Christopher Riffkin, Marika Salmanidis, Lavinia Gordon, Dean Popovski, Lin Rigby, David M Ashley, David N Watkins, David M Thomas, Elizabeth Algar and Paul G Ekert
    Citation: BMC Cancer 2013 13:585
  6. The association of reproductive factors with hormone receptor (HR)-negative breast tumors remains uncertain.

    Authors: Rebecca Ritte, Kaja Tikk, Annekatrin Lukanova, Anne Tjønneland, Anja Olsen, Kim Overvad, Laure Dossus, Agnès Fournier, Françoise Clavel-Chapelon, Verena Grote, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Pagona Lagiou, Dimitrios Trichopoulos, Domenico Palli…
    Citation: BMC Cancer 2013 13:584
  7. This study evaluated the efficacy and safety of S-1 combined with docetaxel (SD) following doxorubicin plus cyclophosphamide (AC) as neoadjuvant therapy in patients with HER2-negative, stage II-III breast cancer.

    Authors: Yong Wha Moon, Soohyeon Lee, Byeong-Woo Park, Eun-Kyung Kim, Seung Il Kim, Ja Seung Koo, Seho Park, Min Jung Kim, Hyun Cheol Chung, Joo-Hang Kim and Joohyuk Sohn
    Citation: BMC Cancer 2013 13:583
  8. We previously found that the low frequency magnetic fields (LF-MF) inhibited gastric and lung cancer cell growth. We suppose that exposure to LF-MF may modulate immune function so as to inhibit tumor. We here ...

    Authors: Yunzhong Nie, Leilei Du, Yongbin Mou, Zhenjun Xu, Leihua Weng, Youwei Du, Yanan Zhu, Yayi Hou and Tingting Wang
    Citation: BMC Cancer 2013 13:582
  9. Serine-threonine inhibitors, such as vemurafenib, are being used increasingly in cancer treatment, and the toxicity and therapeutic benefit need to be balanced carefully both before and during treatment.

    Authors: Mahesh Iddawela, Sarah Crook, Leah George, Amit Lakkaraju, Nihal Nanayakkara, Roland Hunt and William R Adam
    Citation: BMC Cancer 2013 13:581
  10. Osteosarcoma is the most frequent primary malignant bone tumor, notorious for its lung metastasis. Shikonin, an effective constituent extracted from Chinese medicinal herb, was demonstrated to induce necroptos...

    Authors: Zeze Fu, Biyong Deng, Yuxin Liao, Liancheng Shan, Fei Yin, Zhuoying Wang, Hui Zeng, Dongqing Zuo, Yingqi Hua and Zhengdong Cai
    Citation: BMC Cancer 2013 13:580
  11. Owing to the high mortality and rapidly growing costs related to lung cancer, it is worth examining the health benefits of prevention for major types of lung cancer. This study attempts to quantify the quality...

    Authors: Szu-Chun Yang, Wu-Wei Lai, Wu-Chou Su, Shang-Yin Wu, Helen HW Chen, Yi-Lin Wu, Mei-Chuan Hung and Jung-Der Wang
    Citation: BMC Cancer 2013 13:579
  12. Esophageal cancer is the sixth leading cause of cancer death worldwide; current early detection screening tests are inadequate. Esophageal balloon cytology successfully retrieves exfoliated and scraped superfi...

    Authors: Shih-Wen Lin, Christian C Abnet, Neal D Freedman, Gwen Murphy, Rosana Risques, Donna Prunkard, Peter Rabinovitch, Qin-Jing Pan, Mark J Roth, Guo-Qing Wang, Wen-Qiang Wei, Ning Lu, Philip R Taylor, You-Lin Qiao and Sanford M Dawsey
    Citation: BMC Cancer 2013 13:578
  13. Palliative gastrectomy for patients with advanced gastric cancer remains controversial. The objective of the present meta-analysis was to analyze survival outcomes and establish a consensus on whether palliati...

    Authors: Jingxu Sun, Yongxi Song, Zhenning Wang, Xiaowan Chen, Peng Gao, Yingying Xu, Baosen Zhou and Huimian Xu
    Citation: BMC Cancer 2013 13:577
  14. Circumferential resection margin (CRM) and distal resection margin (DRM) have different impact on clinical outcomes after preoperative chemoradiotherapy (CRT) followed by surgery. Effect and adequate length of...

    Authors: Joo Ho Lee, Eui Kyu Chie, Kyubo Kim, Seung-Yong Jeong, Kyu Joo Park, Jae-Gahb Park, Gyeong Hoon Kang, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang and Sung W Ha
    Citation: BMC Cancer 2013 13:576
  15. Flotillin-1 and flotillin-2 are two homologous and ubiquitously expressed proteins that are involved in signal transduction and membrane trafficking. Recent studies have reported that flotillins promote breast...

    Authors: Nina Kurrle, Wymke Ockenga, Melanie Meister, Frauke Völlner, Sina Kühne, Bincy A John, Antje Banning and Ritva Tikkanen
    Citation: BMC Cancer 2013 13:575
  16. Tumor cells benefit from their ability to avoid apoptosis and invade other tissues. The endoplasmic reticulum (ER) membrane protein Sec62 is a key player in these processes. Sec62 is essential for cell migrati...

    Authors: Maximilian Linxweiler, Stefan Schorr, Nico Schäuble, Martin Jung, Johannes Linxweiler, Frank Langer, Hans-Joachim Schäfers, Adolfo Cavalié, Richard Zimmermann and Markus Greiner
    Citation: BMC Cancer 2013 13:574
  17. We are using ACI and BN rats, which differ markedly in their susceptibility to 17β-estradiol (E2)-induced mammary cancer, to identify genetic variants and environmental factors that determine mammary cancer su...

    Authors: Lina Ding, Yang Zhao, Christopher L Warren, Ruth Sullivan, Kevin W Eliceiri and James D Shull
    Citation: BMC Cancer 2013 13:573
  18. While recent research has shown that expression of ZEB-1 in a variety of tumors has a crucial impact on patient survival, there is little information regarding ZEB-1 expression in hepatocellular carcinoma (HCC...

    Authors: Motoyuki Hashiguchi, Shinichi Ueno, Masahiko Sakoda, Satoshi Iino, Kiyokazu Hiwatashi, Koji Minami, Kei Ando, Yuko Mataki, Kosei Maemura, Hiroyuki Shinchi, Sumiya Ishigami and Shoji Natsugoe
    Citation: BMC Cancer 2013 13:572
  19. Phenethyl isothiocyanate (PEITC) is a cancer chemopreventive agent from cruciferous vegetables. Cholangiocarcinoma (CCA) is a chemo-resistant cancer with very poor prognosis. We evaluated the effects of PEITC ...

    Authors: Ornanong Tusskorn, Laddawan Senggunprai, Auemduan Prawan, Upa Kukongviriyapan and Veerapol Kukongviriyapan
    Citation: BMC Cancer 2013 13:571
  20. The placenta-specific 1 (PLAC1) gene encodes a membrane-associated protein which is selectively expressed in the placental syncytiotrophoblast and in murine fetal tissues during embryonic development. In contrast...

    Authors: Meike Wagner, Michael Koslowski, Claudia Paret, Marcus Schmidt, Özlem Türeci and Ugur Sahin
    Citation: BMC Cancer 2013 13:570
  21. Biomarkers allowing the characterization of malignancy and therapy response of oral squamous cell carcinomas (OSCC) or other types of carcinomas are still outstanding. The biochemical suicide molecule endonucl...

    Authors: Martin Grimm, Steffen Schmitt, Peter Teriete, Thorsten Biegner, Arnulf Stenzl, Jörg Hennenlotter, Hans-Joachim Muhs, Adelheid Munz, Tatjana Nadtotschi, Klemens König, Jörg Sänger, Oliver Feyen, Heiko Hofmann, Siegmar Reinert and Johannes F Coy
    Citation: BMC Cancer 2013 13:569
  22. Optimal therapy for patients with unresectable locally advanced extrahepatic cholangiocarcinoma (ULAC) remains controversial. We analysed the role of radiotherapy in the management of such tumors.

    Authors: Laurence Moureau-Zabotto, Olivier Turrini, Michel Resbeut, Jean-Luc Raoul, Marc Giovannini, Flora Poizat, Gilles Piana, Jean-Robert Delpero and Francois Bertucci
    Citation: BMC Cancer 2013 13:568
  23. The incidence of brain metastasis from hepatocellular carcinoma (HCC) is expected to increase as a result of prolonged survival due to the recent advances in HCC treatment. However, there is no definite treatm...

    Authors: Moon-Soo Han, Kyung-Sub Moon, Kyung-Hwa Lee, Sung-Bum Cho, Sa-Hoe Lim, Woo-Youl Jang, Tae-Young Jung, In-Young Kim and Shin Jung
    Citation: BMC Cancer 2013 13:567
  24. DNA methylation is a well-known epigenetic mechanism involved in epigenetic gene regulation. Several genes were reported hypermethylated in CRC, althought no gene marker was proven to be individually of suffic...

    Authors: Jean-Pierre Roperch, Roberto Incitti, Solène Forbin, Floriane Bard, Hicham Mansour, Farida Mesli, Isabelle Baumgaertner, Francesco Brunetti and Iradj Sobhani
    Citation: BMC Cancer 2013 13:566
  25. Lifestyle factors, including food and nutrition, physical activity, body composition and reproductive factors, and single nucleotide polymorphisms (SNPs) are associated with breast cancer risk, but few studies...

    Authors: Taeko Mizoo, Naruto Taira, Keiko Nishiyama, Tomohiro Nogami, Takayuki Iwamoto, Takayuki Motoki, Tadahiko Shien, Junji Matsuoka, Hiroyoshi Doihara, Setsuko Ishihara, Hiroshi Kawai, Kensuke Kawasaki, Youichi Ishibe, Yutaka Ogasawara, Yoshifumi Komoike and Shinichiro Miyoshi
    Citation: BMC Cancer 2013 13:565
  26. Treatment of early and multiple cutaneous unresectable recurrences is a major therapeutic problem with around 80% of patients relapsing within 5 years. For lesions refractory to elective treatments, electroche...

    Authors: Corrado Caracò, Nicola Mozzillo, Ugo Marone, Ester Simeone, Lucia Benedetto, Gianluca Di Monta, Maria Luisa Di Cecilia, Gerardo Botti and Paolo Antonio Ascierto
    Citation: BMC Cancer 2013 13:564
  27. Myxofibrosarcoma comprises a spectrum of malignant neoplasms withprominent myxoid stromata, cellular pleomorphism, and distinct curvilinear vascular patterns. These neoplasms mainly affect patients in the sixt...

    Authors: Birgit Lohberger, Nicole Stuendl, Elisabeth Wolf, Bernadette Liegl-Atzwanger, Andreas Leithner and Beate Rinner
    Citation: BMC Cancer 2013 13:563
  28. Genetic BRCA2 insufficiency is associated with breast cancer development; however, in sporadic breast cancer cases, high BRCA2 expression is paradoxically correlated with poor prognosis. Because DSS1, a mammal...

    Authors: Andri Rezano, Kazuhiko Kuwahara, Mutsuko Yamamoto-Ibusuki, Masahiro Kitabatake, Penpak Moolthiya, Suchada Phimsen, Taiji Suda, Shigenobu Tone, Yutaka Yamamoto, Hirotaka Iwase and Nobuo Sakaguchi
    Citation: BMC Cancer 2013 13:562
  29. Vemurafenib, an inhibitor of genetically activated BRAF, is now commonly prescribed for metastatic melanoma harboring a BRAF mutation. Reports on side effects have focused on cutaneous complications. We here pres...

    Authors: Sanne EJ Wolf, Christina Meenken, Annette C Moll, John B Haanen and Michiel S van der Heijden
    Citation: BMC Cancer 2013 13:561
  30. The aim of this study was to evaluate the role of family history of cancer and personal history of other medical conditions in the aetiology of the oral cavity cancer in France.

    Authors: Loredana Radoï, Sophie Paget-Bailly, Florence Guida, Diane Cyr, Gwenn Menvielle, Annie Schmaus, Matthieu Carton, Sylvie Cénée, Marie Sanchez, Anne-Valérie Guizard, Brigitte Trétarre, Isabelle Stücker and Danièle Luce
    Citation: BMC Cancer 2013 13:560
  31. A diagnosis of prostate cancer leads to emotional distress and anxiety, prompting calls for rapid diagnostic pathways. Nevertheless, it remains unclear what impact time between diagnosis and surgery has upon p...

    Authors: Maria Theresa Redaniel, Richard M Martin, David Gillatt, Julia Wade and Mona Jeffreys
    Citation: BMC Cancer 2013 13:559
  32. The St Gallen surrogate molecular subtype definitions classify the oestrogen (ER) positive breast cancer into the luminal A and luminal B subtypes according to proliferation rate and/or expression of human epi...

    Authors: Anna-Karin Falck, Mårten Fernö, Pär-Ola Bendahl and Lisa Rydén
    Citation: BMC Cancer 2013 13:558
  33. WNT signaling pathways are significantly altered during cancer development. Vertebrates possess two classes of WNT signaling pathways: the “canonical” WNT/β-catenin signaling pathway, and the “non-canonical” p...

    Authors: Beatriz García-Castro, Monserrat Alvarez-Zavala, Alma R Riveros-Magaña, Pablo C Ortíz-Lazareno, Sarah Ratkovich-González, Georgina Hernández-Flores, Alejandro Bravo-Cuellar, Luis F Jave-Suarez and Adriana Aguilar-Lemarroy
    Citation: BMC Cancer 2013 13:557
  34. We have previously shown that a functional polymorphism of the UGT2B15 gene (rs1902023) was associated with increased risk of prostate cancer (PC). Novel functional polymorphisms of the UGT2B17 and UGT2B15 genes ...

    Authors: Adriana C Vidal, Cocoa Tucker, Joellen M Schildkraut, Ricardo M Richardson, Megan McPhail, Stephen J Freedland, Cathrine Hoyo and Delores J Grant
    Citation: BMC Cancer 2013 13:556
  35. Glutamate decarboxylase 1 (GAD1), a rate-limiting enzyme in the production of γ-aminobutyric acid (GABA), is found in the GABAergic neurons of the central nervous system. Little is known about the relevance of...

    Authors: Ryota Kimura, Atsushi Kasamatsu, Tomoyoshi Koyama, Chonji Fukumoto, Yukinao Kouzu, Morihiro Higo, Yosuke Endo-Sakamoto, Katsunori Ogawara, Masashi Shiiba, Hideki Tanzawa and Katsuhiro Uzawa
    Citation: BMC Cancer 2013 13:555
  36. Pancreatic cancer (PC) is an aggressive disease with an urgent need for biomarkers. Hallmarks of PC include increased collagen deposition (desmoplasia) and increased matrix metalloproteinase (MMP) activity. Th...

    Authors: Nicholas Willumsen, Cecilie L Bager, Diana J Leeming, Victoria Smith, Morten A Karsdal, David Dornan and Anne-Christine Bay-Jensen
    Citation: BMC Cancer 2013 13:554
  37. Data on the current burden of adenocarcinoma (ADC) and histology-specific human papillomavirus (HPV) type distribution are relevant to predict the future impact of prophylactic HPV vaccines.

    Authors: Jeanne M Pimenta, Claudia Galindo, David Jenkins and Sylvia M Taylor
    Citation: BMC Cancer 2013 13:553
  38. The tumor suppressor p53 is a sequence-specific transcription factor that regulates an extensive network of coding genes, long non-coding RNAs and microRNAs, that establish intricate gene regulatory circuits i...

    Authors: Alessandra Bisio, Veronica De Sanctis, Valerio Del Vescovo, Michela A Denti, Anil G Jegga, Alberto Inga and Yari Ciribilli
    Citation: BMC Cancer 2013 13:552
  39. Heterogeneous echogenicity of the thyroid gland has been associated with diffuse thyroid disease and benign and malignant nodules can coexist with diffuse thyroid disease. Underlying heterogeneous echogenicity...

    Authors: Mina Park, So Hee Park, Eun-Kyung Kim, Jung Hyun Yoon, Hee Jung Moon, Hye Sun Lee and Jin Young Kwak
    Citation: BMC Cancer 2013 13:550
  40. Resistance to platinum-based chemotherapy remains a major impediment in the treatment of serous epithelial ovarian cancer. The objective of this study was to use gene expression profiling to delineate major de...

    Authors: Madhuri Koti, Robert J Gooding, Paulo Nuin, Alexandria Haslehurst, Colleen Crane, Johanne Weberpals, Timothy Childs, Peter Bryson, Moyez Dharsee, Kenneth Evans, Harriet E Feilotter, Paul C Park and Jeremy A Squire
    Citation: BMC Cancer 2013 13:549
  41. Replanning in intensity-modulated radiotherapy (IMRT) has been reported to improve quality of life and loco-regional control in patients with nasopharyngeal cancer (NPC). Determination of the criteria for repl...

    Authors: DanFang Yan, SenXiang Yan, QiDong Wang, XinBiao Liao, ZhongJie Lu and YiXiang Wang
    Citation: BMC Cancer 2013 13:548
  42. Nivestim™ (filgrastim) is a follow-on biologic agent licensed in the EU for the treatment of neutropenia and febrile neutropenia induced by myelosuppressive chemotherapy. Nivestim™ has been studied in phase 2 ...

    Authors: Didier Kamioner, Stefan Fruehauf, Fréderic Maloisel, Laurent Cals, Stéphane Lepretre and Christian Berthou
    Citation: BMC Cancer 2013 13:547
  43. The chemotherapy resistance of non-small cell lung cancer (NSCLC) remains a clinic challenge and is closely associated with several biomarkers including epidermal growth factor receptor (EGFR) ( Drugs 72(Suppl...

    Authors: Xiao-Yi Duan, Wen Wang, Jian-Sheng Wang, Jin Shang, Jun-Gang Gao and You-Min Guo
    Citation: BMC Cancer 2013 13:546
  44. The present study focused on the prognostic roles of PIK3CA and PIK3R1 genes and additional PI3K pathway-associated genes in breast cancer.

    Authors: Magdalena Cizkova, Sophie Vacher, Didier Meseure, Martine Trassard, Aurélie Susini, Dana Mlcuchova, Celine Callens, Etienne Rouleau, Frederique Spyratos, Rosette Lidereau and Ivan Bièche
    Citation: BMC Cancer 2013 13:545
  45. During cancer treatment children have reduced contact with their social network of friends, and have limited participation in education, sports, and leisure activities. During and following cancer treatment, c...

    Authors: Troels Thorsteinsson, Anne Sofie Helms, Lis Adamsen, Lars Bo Andersen, Karen Vitting Andersen, Karl Bang Christensen, Henrik Hasle, Carsten Heilmann, Nete Hejgaard, Christoffer Johansen, Marianne Madsen, Svend Aage Madsen, Venka Simovska, Birgit Strange, Lone Friis Thing, Peder Skov Wehner…
    Citation: BMC Cancer 2013 13:544
  46. Nowadays, evaluation of colorectal cancer prognosis and decision-making for treatment continues to be based primarily on TNM tumour stage. Administration of adjuvant chemotherapy is especially challenging for ...

    Authors: Daniel Ayude, Francisco Javier Rodríguez-Berrocal, José Ayude, Sonia Blanco-Prieto, Lorena Vázquez-Iglesias, Marta Vázquez-Cedeira and María Páez de la Cadena
    Citation: BMC Cancer 2013 13:543
  47. Systemic capillary leak syndrome is a rare disease with a high mortality rate. This syndrome is characterised by generalised edema, hypotension, hemoconcentration, and hypoproteinemia. The cause is the sudden ...

    Authors: Andrea Casadei Gardini, Michele Aquilina, Devil Oboldi, Alessandro Lucchesi, Silvia Carloni, Elena Tenti, Marco Angelo Burgio, Dino Amadori and Giovanni Luca Frassineti
    Citation: BMC Cancer 2013 13:542
  48. The purpose of the present study was to retrospectively evaluate whether copy number changes of the genes encoding the ribonucleotide reductase subunit M1 (RRM1) and/or subunit M2B (RRM2B) predict sensitivity to ...

    Authors: Charlotte LT Jørgensen, Bent Ejlertsen, Karsten D Bjerre, Eva Balslev, Dorte L Nielsen and Kirsten V Nielsen
    Citation: BMC Cancer 2013 13:541

Featured videos

View featured videos from across the BMC-series journals